Hepatology
Displaying 1 - 21 of 21
Singal, A. G., Quirk, L., Boike, J., Chernyak, V., Feng, Z., Giamarqo, G., Kanwal, F., Ioannou, G. N., Manes, S., Marrero, J. A., Mehta, N., Pillai, A., Shaheen, N. J., Shaukat, A., Sirlin, C. B., Verna, E., Wani, S., Wilson Woods, A., Yang, J. D., & Parikh, N. D. (2024). Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel. Hepatology. https://doi.org/10.1097/hep.0000000000001203
Publication Date
Columbia Affiliation
View
Pang, Z., Zhang, H., Zheng, S., Yang, X., Liu, C., Han, Q., Chen, Y., Li, Z., Zhang, X., Cao, L., Wang, Q., Cao, Y., Sun, X., Zhao, P., Li, X., Zheng, Q., & Sheng, R. (2024). HNF4α-CDKL3 axis restricts MASLD progression by targeting FoxO1 via non-canonical phosphorylation. Hepatology. https://doi.org/10.1097/hep.0000000000001147
Publication Date
Columbia Affiliation
View
Dunn, W., Li, Y., Singal, A. K., Simonetto, D. A., Díaz, L. A., Idalsoaga, F., Ayares, G., Arnold, J., Ayala-Valverde, M., Perez, D., Gomez, J., Escarate, R., Fuentes-López, E., Ramirez-Cadiz, C., Morales-Arraez, D., Zhang, W., Qian, S., Ahn, J. C., Buryska, S., … Arab, J. P. (2024). An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study. Hepatology, 80(5), 1196–1211. https://doi.org/10.1097/hep.0000000000000883
Publication Date
Columbia Affiliation
Hsu, C. L., Wang, L., Maestri, E., Jacob, A. R., Do, W. L., Mayo, S., Bosques-Padilla, F., Verna, E. C., Abraldes, J. G., Brown Jr., R. S., Vargas, V., Altamirano, J., Caballería, J., Shawcross, D. L., Louvet, A., Lucey, M. R., Mathurin, P., Garcia-Tsao, G., Stärkel, P., … Schnabl, B. (2024). Viral antibody response predicts morbidity and mortality in alcohol-associated hepatitis. Hepatology. https://doi.org/10.1097/hep.0000000000001046
Publication Date
Columbia Affiliation
View
Untalan, M., A. Crimmins, N., Yates, K. P., A. Mencin, A., A. Xanthakos, S., & Thaker, V. V. (2024). Prevalence of subclinical hypothyroidism and longitudinal thyroid-stimulating hormone changes in youth with metabolic dysfunction–associated steatotic liver disease: An observational study. Hepatology. https://doi.org/10.1097/hep.0000000000001095
Publication Date
Columbia Affiliation
View
Nobel, Y. R., Boike, J. R., Mazumder, N. R., Thornburg, B., Hoffman, R., Kolli, K. P., Fallon, M., Lai, J. C., Morelli, G., Spengler, E. K., Said, A., Desai, A. P., Paul, S., Goel, A., Hu, K., Frenette, C., Gregory, D., Padilla, C., … Zhang, Y. (2024). Predictors of long-term clinical outcomes after TIPS: An ALTA group study. Hepatology. https://doi.org/10.1097/hep.0000000000001091
Publication Date
Columbia Affiliation
View
Wang, M., Chiou, S. H., Ganger, D., Ruck, J., Huang, C.-Y., Kappus, M. R., King, E. A., Ladner, D. P., Rahimi, R. S., Duarte-Rojo, A., Volk, M. L., Tevar, A. D., Verna, E. C., & Lai, J. C. (2024). Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Hepatology. https://doi.org/10.1097/hep.0000000000001030
Publication Date
Columbia Affiliation
View
Moore, M. P., Wang, X., Kennelly, J. P., Shi, H., Ishino, Y., Kano, K., Aoki, J., Cherubini, A., Ronzoni, L., Guo, X., Chalasani, N. P., Khalid, S., Saleheen, D., Mitsche, M. A., Rotter, J. I., Yates, K. P., Valenti, L., Kono, N., Tontonoz, P., & Tabas, I. (2024). Low MBOAT7 expression, a genetic risk for MASH, promotes a profibrotic pathway involving hepatocyte TAZ upregulation. Hepatology. https://doi.org/10.1097/hep.0000000000000933
Publication Date
Columbia Affiliation
View
Sun, C., Zhou, C., Daneshvar, K., Ben Saad, A., Kratkiewicz, A. J., Toles, B. J., Arghiani, N., Hess, A., Chen, J. Y., Pondick, J. V., York, S. R., Li, W., Moran, S. P., Gentile, S. D., Rahman, R. U., Li, Z., Zhou, P., Sparks, R. P., Habboub, T., … Mullen, A. C. (2024). Conserved long noncoding RNA TILAM promotes liver fibrosis through interaction with PML in HSCs. Hepatology. https://doi.org/10.1097/hep.0000000000000822
Publication Date
Columbia Affiliation
View
Hassan, M. M., Li, D., Han, Y., Byun, J., Hatia, R. I., Long, E., Choi, J., Kelley, R. K., Cleary, S. P., Lok, A. S., Bracci, P., Permuth, J. B., Bucur, R., Yuan, J.-M., Singal, A. G., Jalal, P. K., Ghobrial, R. M., Santella, R. M., Kono, Y., … Amos, C. I. (2024). Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology, 80(1), 87–101. https://doi.org/10.1097/hep.0000000000000800
Publication Date
Columbia Affiliation
Yamazaki, T., Kouno, T., Hsu, C. L., Hartmann, P., Mayo, S., Zhang, X., Stärkel, P., Bosques-Padilla, F., Verna, E. C., Abraldes, J. G., Brown, R. S., Vargas, V., Altamirano, J., Caballería, J., Shawcross, D. L., Louvet, A., Lucey, M. R., Mathurin, P., … Garcia-Tsao, G. (2024). Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis. Hepatology, 80(2), 403–417. https://doi.org/10.1097/hep.0000000000000777
Publication Date
Columbia Affiliation
Wang, X., Zhang, L., & Dong, B. (2024). Molecular mechanisms in MASLD/MASH-related HCC. Hepatology. https://doi.org/10.1097/hep.0000000000000786
Publication Date
Columbia Affiliation
View
Lazarus, J. V., Mark, H. E., Allen, A. M., Arab, J. P., Carrieri, P., Noureddin, M., Alazawi, W., Alkhouri, N., Alqahtani, S. A., Anstee, Q. M., Arrese, M., Bataller, R., Berg, T., Brennan, P. N., Burra, P., Castro-Narro, G. E., Cortez-Pinto, H., Cusi, K., … Dedes, N. (2023). A global action agenda for turning the tide on fatty liver disease. Hepatology, 79(2), 502–523. https://doi.org/10.1097/hep.0000000000000545
Publication Date
Columbia Affiliation
View
van Zwol, W., Rimbert, A., Wolters, J. C., Smit, M., Bloks, V. W., Kloosterhuis, N. J., Huijkman, N. C. A., Koster, M. H., Tharehalli, U., de Neck, S. M., Bournez, C., Fuh, M. M., Kuipers, J., Rajan, S., de Bruin, A., Ginsberg, H. N., van Westen, G. J. P., Hussain, M. M., Scheja, L., … Kuivenhoven, J. A. (2022). Loss of hepatic SMLR1 causes hepatosteatosis and protects against atherosclerosis due to decreased hepatic VLDL secretion. Hepatology, 78(5), 1418–1432. https://doi.org/10.1002/hep.32709
Publication Date
Columbia Affiliation
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., Tabibian, J. H., & Assis, D. N. (2023). Reply: Insurance should cover vancomycin for primary sclerosing cholangitis. Hepatology, 77(6), E176–E177. https://doi.org/10.1097/hep.0000000000000305
Publication Date
Columbia Affiliation
View
Bommena, S., Mahmud, N., Boike, J. R., Thornburg, B. G., Kolli, K. P., Lai, J. C., German, M., Morelli, G., Spengler, E., Said, A., Desai, A. P., Junna, S., Paul, S., Frenette, C., Verna, E. C., Goel, A., Gregory, D., Padilla, C., … VanWagner, L. B. (2023). The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology, 77(6), 2041–2051. https://doi.org/10.1097/hep.0000000000000283
Publication Date
Columbia Affiliation
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., Tabibian, J. H., & Assis, D. N. (2022). AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma. Hepatology, 77(2), 659–702. https://doi.org/10.1002/hep.32771
Publication Date
Columbia Affiliation
Cullaro, G., Verna, E. C., McCulloch, C. E., & Lai, J. C. (2022). Improving the Model for End‐Stage Liver Disease with sodium by incorporating kidney dysfunction types. Hepatology, 76(3), 689–699. https://doi.org/10.1002/hep.32448
Publication Date
Columbia Affiliation
Vos, M. B., Van Natta, M. L., Blondet, N. M., Dasarathy, S., Fishbein, M., Hertel, P., Jain, A. K., Karpen, S. J., Lavine, J. E., Mohammad, S., Miriel, L. A., Molleston, J. P., Mouzaki, M., Sanyal, A., Sharkey, E. P., Schwimmer, J. B., Tonascia, J., Wilson, L. A., & Xanthakos, S. A. (2022). Randomized placebo‐controlled trial of losartan for pediatric NAFLD. Hepatology, 76(2), 429–444. https://doi.org/10.1002/hep.32403
Publication Date
Columbia Affiliation
Lai, J. C., Shui, A. M., Duarte‐Rojo, A., Ganger, D. R., Rahimi, R. S., Huang, C., Yao, F., Kappus, M., Boyarsky, B., McAdams‐Demarco, M., Volk, M. L., Dunn, M. A., Ladner, D. P., Segev, D. L., Verna, E. C., & Feng, S. (2021). Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. Hepatology, 75(6), 1471–1479. https://doi.org/10.1002/hep.32268
Publication Date
Columbia Affiliation
View
Fox, A. N., Liapakis, A., Batra, R., Bittermann, T., Emamaullee, J., Emre, S., Genyk, Y., Han, H., Jackson, W., Pomfret, E., Raza, M., Rodriguez‐Davalos, M., Rubman Gold, S., Samstein, B., Shenoy, A., Taner, T., & Roberts, J. P. (2022). The use of nondirected donor organs in living donor liver transplantation: Perspectives and guidance. Hepatology, 75(6), 1579–1589. https://doi.org/10.1002/hep.32260
Publication Date
Columbia Affiliation